FDA Policy/General
Reg Update on Non-Animal Testing Methods in Drug Development
FDA has issued a direct final rule updating its regulations to clarify that non-animal testing methods may be used, where appropriate, to establish the safety of drugs and biological products before human clinical trials. The 9/21 rule replaces references to “animal tests” and “animal studies” with the broader